https://www.selleckchem.com/pr....oducts/oxidopamine-h
Presence of a syndrome (or association) is predictive of poor survival in esophageal atresia (EA). However, most reports rely on historical patient outcomes, limiting their usefulness when estimating risk for neonates born today. We hypothesized improved syndromic EA survival due to advances in neonatal care. A retrospective single-center review of survival in 626 consecutive patients with EA from 1980 to 2017 was performed. Data were collected for recognized risk factors preterm delivery; birth weight 1500 g; major
Beğen
Yorum Yap
Paylaş
